Biochemical Pharmacology as an Approach to Gastrointestinal Disorders: Basic Science to Clinical Perspectives (1996) Book

	Participants
	Preface
	Introduction: Advances in the biochemical pharmacology of gastrointestinal (GI) functions as an approach to understanding GI disorders	1
	Possible compensation in epidermal growth factor production by saliva in rat	7
	Regulatory mechanism of acid secretion in rat stomach after damage - role of nitric oxide, histamine and sensory neurons	25
	Secretory pathways in histamine-containing enterochromaffin-like cells of rat stomach	39
	Nitric oxide as a modulator of fluid absorption in rat jejunum in vivo	57
	Mechanism of cholera	65
	Critical evaluation of acinar, ductal, vascular and intestinal intraluminal factors influencing pancreatic cytoprotection	73
	Peptide receptor antagonists and monoclonal antibodies raised against peptides: tools to study physiological regulation of pancreatic function	83
	Mechanisms and regulation of Cl secretion in the large intestine: studies with the rat distal colon	95
	Prostaglandin E[subscript 2]: actions on the circular and longitudinal contractions of the canine colon	105
	Gastric motor effects of endothelins in the lower brainstem of the rat	115
	Effects of erythromycin on the propulsive motility of upper gastrointestinal tract in rats	125
	Bicuculline blocks the inhibitory effects of substance P but not vasoactive intestinal polypeptide on gastric motor function in the nucleus raphe obscurus of the rat	131
	Pathological basis and clinical aspects of oesophageal motor disorders	141
	Distribution of muscarinic receptor mRNAs in the stomach of normal or immobilized rats	171
	Changes of sensory neuropeptides in experimental gastrointestinal diseases	187
	Biochemical energetical backgrounds and their regulation in the gastric corpus mucosa in patients with different gastric secretory responses	199
	Oxidative stress and its prevention in toxic liver lesions. An overview	225
	The effect of drugs on liver function and biliary secretion	239
	Alteration of microvascular regeneration and permeability during acetic acid-induced gastric ulcer healing: effect of basic fibroblast growth factor	249
	Modulation of gastric wound repair by hepatocyte growth factor and basic fibroblast growth factor	261
	The effect of resiniferatoxin on experimental gastric ulcer in rats	269
	AIDS treatment and the heat shock protein level in the gastrointestinal tract	287
	ELISA and Western blot studies with basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) in experimental duodenal ulceration and healing	297
	Biological oxidants as intestinal secretagogues	303
	A new uniform biochemical explanation for the development and location of 'genuine' gastric, duodenal and jejunal ulcers in patients	313
	Current problems and results of tumour immunology: diagnostic and therapeutic relevance of tumour-associated antigens	337
	Does omeprazole-induced hypergastrinaemia contribute to the enhanced healing of acetic acid-induced gastric ulcers in rats?	349
	Modification of pathobiological events by potential hepatopharmacological agents	361
	Organoprotection and cytoprotection of histamine differ in rats	373
	Comparative viability studies on isolated gastric mucosal mixed cells and hepatoma and myeloma cell lines with ethanol, indomethacin and their combination	387
	Index	395